Active substance:
- Feline calicivirus, strains 431 and G1, Inactivated
- Chlamydia felis, strain 905, Live
- Feline panleucopenia virus, strain PLI IV, Live
- Felid herpesvirus 1, strain F2, Live
- Canarypox virus, strain vCP97, expressing env and gag genes and a portion of the pol gene of Feline leukemia virus, Live
Route of administration:
-
Subcutaneous use
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Target species:
-
Cat
Available in:
-
Belgium
-
Czechia
-
France
-
Luxembourg
-
Poland
-
Slovakia
-
Spain